Related Experiment Videos
Efficient route to C2 symmetric heterocyclic backbone modified cyclic peptides
Jan H van Maarseveen1, W Seth Horne, M Reza Ghadiri
1Department of Chemistry, Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.
Organic Letters
|September 24, 2005
Summary
This study introduces a new method for creating cyclic peptide scaffolds using a tandem dimerization-macrocyclization process. This approach efficiently synthesizes C2 symmetric structures with triazole amino acids, serving as dipeptide surrogates.
Area of Science:
- Organic Chemistry
- Medicinal Chemistry
- Peptide Chemistry
Background:
- Cyclic peptides are important in drug discovery due to their unique structural properties and biological activities.
- Developing efficient synthetic routes for complex cyclic peptide scaffolds remains a challenge in chemical synthesis.
- Triazole amino acids offer versatile functionalities and can act as stable peptide bond mimics.
Purpose of the Study:
- To develop a facile and convergent solution-phase synthesis for C2 symmetric cyclic peptide scaffolds.
- To incorporate triazole epsilon2-amino acids as dipeptide surrogates within these scaffolds.
- To establish a tandem dimerization-macrocyclization strategy for efficient scaffold construction.
Main Methods:
- Employed a tandem dimerization-macrocyclization approach.
- Utilized 1,3-dipolar azide-alkyne cycloaddition reactions for scaffold assembly.
- Conducted synthesis in solution phase for accessibility and scalability.
Main Results:
- Successfully synthesized C2 symmetric cyclic peptide scaffolds.
- Demonstrated the utility of triazole epsilon2-amino acids as dipeptide surrogates.
- Achieved facile and convergent synthesis, highlighting the efficiency of the tandem approach.
Conclusions:
- The developed tandem dimerization-macrocyclization strategy provides an efficient route to novel cyclic peptide scaffolds.
- This method allows for the incorporation of triazole amino acids, expanding the chemical space for peptide-based therapeutics.
- The synthesized scaffolds hold potential for applications in medicinal chemistry and drug development.